World Molecular Imaging Congress 2017: IMAGinING the Future: from Molecules to Medicine
World Molecular Imaging Congress 2017: IMAGinING the Future: from Molecules to Medicine
批准号:
9398016
负责人:
SANJIV S GAMBHIR
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-15 至 2018-07-14
关键词:
AcademyAreaBiologyCaliforniaCardiologyChemistryClinicClinicalCommunicable DiseasesCommunitiesComprehensionCongressesDetectionDevelopmentDiagnosticDisabled PersonsDisciplineDiseaseEndocrinologyEquilibriumEventFundingFutureGenderGoalsHeadHealthHealthcareHumanImaging technologyIndividualIndustryInterest GroupInternationalInterventionInvestigationLearningLifeMalignant NeoplasmsMedicineMissionMolecular BiologyNeurologyPathologic ProcessesPatient CarePennsylvaniaPhasePhiladelphiaPhysiciansPlayPostdoctoral FellowResearch PersonnelRheumatologyRoleScienceScientistSecureSeminalSocietiesStudentsTrainingTravelUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesWomanWorkanticancer researchcareer developmentcellular imagingclinical applicationclinical imagingcollegecostgraduate studenthuman diseaseimage guided therapyin vivo imaginginnovationinsightinterestmedical specialtiesmeetingsmembermolecular imagingmultidisciplinarymultimodalitynext generationnoveloncologypre-clinicalprofessorprognosticprogramstranslational scientist
中文摘要
摘要
分子成像(MI)在理解、检测和分析生物多样性方面取得了革命性的应用
治疗几乎所有人类疾病。MI领域代表着不同科学领域的融合
包括成像技术、分子生物学和化学在内的领域,提供了主要的
为科学界带来新的见解和进展。世界分子影像学会
(世界管理信息系统)将管理信息领域体现为一个致力于发展和促进
在原子水平上了解和有效地了解各种类型的临床前和临床影像
治疗经常危及生命的各种专科疾病,如肿瘤学、传染性
疾病、神经学、心脏病学、风湿病学和内分泌学。的一个显著特点
我们的社会是高度整合的多模式方法,从科学创新到
诊所里的病人护理。作为一个国际科学教育组织,活跃的成员
WMI的成员包括基础和翻译科学家、临床医生、青年研究人员和学生
来自广泛的学科,有一个致力于理解生物学的共同目标
和医学通过体内细胞和分子事件的多模式成像
定量心肌梗死的正常和病理过程及其在患者护理中的应用。一年一度的
世界分子成像大会(WMIC)面向世界分子成像协会成员和非成员举行
对该领域感兴趣,来自学术界和工业界,是唯一
MI的综合性国际会议。事实上,WMIC是MI的缩影,
为具有不同背景的科学家和临床医生提供了一个互动、展示、
并讨论和跟踪前沿进展。世界管理信息系统正在积极寻求机制,以
保持这一多学科变革性领域的动力和快速发展,
特别是通过确保博士后研究员和研究生的旅行资金。这些
个人未来将在决定如何在医疗保健中利用MI方面发挥作用。此R13的目标是
是获得特定的资金,以支付支持学生参加研究生课程的费用
和博士后水平,特别是鼓励妇女、代表不足的少数民族和
残疾人,使他们能够参加明年#年的WMIC年度会议
2017年9月13日至16日,宾夕法尼亚州费城。
英文摘要
ABSTRACT
Molecular imaging (MI) is finding transformative applications in the understanding, detection and
treatment of nearly all human diseases. The field of MI represents a fusion of diverse scientific
fields, including imaging technologies, molecular biology, and chemistry, that is providing major
new insights and advances to the scientific community. The World Molecular Imaging Society
(WMIS) embodies the field of MI as an organization dedicated to developing and promoting
preclinical and clinical imaging of various types at the atomic level, to understand and effectively
treat often life-threatening diseases of a variety of specialties, such as in oncology, infectious
disease, neurology, cardiology, rheumatology, and endocrinology. A distinguishing feature of
our society is the highly-integrated, multimodal approach that spans from scientific innovation to
patient care in the clinic. As an international scientific educational organization, active members
of WMIS include basic and translational scientists, clinicians, young researchers and students
from a wide variety of disciplines, with a dedicated common goal to the understanding of biology
and medicine through multimodal in vivo imaging of cellular and molecular events involved in
normal and pathologic processes and utilization of quantitative MI in patient care. The annual
World Molecular Imaging Congress (WMIC) is held for WMIS members and non-members
interested in the field, who come from both academics and industry, and is the only
comprehensive, international meeting of MI. Indeed, the WMIC is the epitome of MI that
provides a platform for scientists and clinicians with diverse backgrounds to interact, present,
and discuss and follow cutting-edge advances. The WMIS is actively seeking mechanisms to
maintain the impetus and rapid trajectories of this multidisciplinary transformative field, in
particular, by securing travel funds for post-doctoral fellows and graduate students. These
individuals will play future roles in deciding how MI is utilized in healthcare. The goal of this R13
is to obtain specific funds to cover costs that support the attendance of students at the graduate
and postdoctoral levels, especially encouraging women, underrepresented minorities and
persons with disabilities, enabling their attendance to the annual WMIC, next year in
Philadelphia, Pennsylvania on September 13-16, 2017.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanoparticle-Based Triple Modality Imaging and Photothermal Therapy of Brain Tumors
-
批准号:9092358
-
项目类别:
-
资助金额:$35.95万
-
财政年份:2016
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Nanoparticle-Based Triple Modality Imaging and Photothermal Therapy of Brain Tumors
-
批准号:9766199
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2016
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Optimization of an activatable photoacoustic agent to image thyroid cancer
-
批准号:9223698
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2015
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Developmental Program
-
批准号:8961578
-
项目类别:
-
资助金额:$15.01万
-
财政年份:2015
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Optimization of an activatable photoacoustic agent to image thyroid cancer
-
批准号:9060321
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2015
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
-
批准号:9324940
-
项目类别:
-
资助金额:$204.91万
-
财政年份:2015
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Vevo LAZR Photoacoustic and Ultrasound Imaging System
-
批准号:8447766
-
项目类别:
-
资助金额:$52.19万
-
财政年份:2013
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Improved Prostate Cancer Detection Using Combined Ultrasound and Photoacoustic Im
-
批准号:8569337
-
项目类别:
-
资助金额:$17.07万
-
财政年份:2013
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Administrative Core
-
批准号:7983248
-
项目类别:
-
资助金额:$10.54万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
-
批准号:8540368
-
项目类别:
-
资助金额:$233.45万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Career Development
-
批准号:7990939
-
项目类别:
-
资助金额:$8.24万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Pilot Projects
-
批准号:7983262
-
项目类别:
-
资助金额:$6.02万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Integration of Nano-Molecular Imaging and Nanosensors
-
批准号:7983246
-
项目类别:
-
资助金额:$19.35万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Monitoring Response to Targeted Therapy in Non-Small Cell Lung Cancer Using 18F..
-
批准号:7990870
-
项目类别:
-
资助金额:$89.3万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Alliance Challenge Projects
-
批准号:7983260
-
项目类别:
-
资助金额:$9.46万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
-
批准号:8134460
-
项目类别:
-
资助金额:$260.52万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Organization and Administration
-
批准号:7990869
-
项目类别:
-
资助金额:$6.9万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Education/Training and Outreach Activities
-
批准号:7983259
-
项目类别:
-
资助金额:$5.16万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
-
批准号:7962349
-
项目类别:
-
资助金额:$275.48万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
Center for Cancer Nanotechnology Excellence and Translation (CCNE-T)
-
批准号:8322769
-
项目类别:
-
资助金额:$255.11万
-
财政年份:2010
-
负责人:SANJIV S GAMBHIR
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: